(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, Sep 15, 2021, 03:26 /Comserve / -- The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024.
COVID-19 has reformed the way we work and has impacted various aspects of the businesses worldwide. Keeping in mind the multi-faceted challenges and the impact on economies post pandemic, companies are focusing on the risks and probabilities for sustainability, growth, and development from this transition.
The global BCG vaccine market is anticipated to reach US$ 65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R & D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.
Fill This Form and get the Sample Copy of This Report:
The Final Report will cover the impact analysis of COVID-19 on this industry: Global BCG Vaccine Market Insights by Latest Trends, Future Growth, Top Companies, Revenue Forecast, Demand Forecast with Potential Impact of COVID-19 (2020-2024)
The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.
The global BCG vaccine market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the market during the period spanning 2020-2024, supported by growing tobacco consumption and increasing technological advancements in BCG vaccination.
Fill This Form and get the Sample Copy of This Report:
The Final Report will cover the impact analysis of COVID-19 on this industry: Global BCG Vaccine Market Insights by Latest Trends, Future Growth, Top Companies, Revenue Forecast, Demand Forecast with Potential Impact of COVID-19 (2020-2024)
Scope of the report:
• The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.
• The major regional markets (North America, Europe and Asia Pacific) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.
Key Target Audience:
• BCG Vaccine Providers/Hospitals
• API Suppliers
• End Users (Businesses/Consumers)
• Investment Banks
• Government Bodies & Regulating Authorities
TABLE OF CONTENT
1. Market Overview
1.1 BCG Vaccine
1.2 Medical Use: Tuberculosis
1.3 Medical Use: Cancer
1.4 Medical Use: Mycobacteria
1.5 Methods of Administration of BCG
1.6 Adverse Effects of BCG
1.7 Precautions to be taken in BCG
1.8 Side Effects of BCG
2. Impact of COVID-19
2.1 Impact on Global Economy
2.2 Change in Organic Traffic
2.3 Global Prevalence of COVID-19
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
MENAFN15092021004694010674ID1102800424
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.